|
LM_ID
|
Common Name
|
Systematic Name
|
Main class
|
Sub class
|
Mass
|
Formula
|
|
LMFA03110250
|
5-epi-12-A2-IsoP
|
4-((1S,2R)-2-((S,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)butanoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110274
|
5-epi-12-J2-IsoP
|
4-((1R,5S)-5-((S,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)butanoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110256
|
5-epi-5-A2-IsoP
|
(R,E)-5-hydroxy-7-((1R,2R)-2-((Z)-oct-2-en-1-yl)-5-oxocyclopent-3-en-1-yl)hept-6-enoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110073
|
5-epi-5-J2-IsoP
|
5R-hydroxy-11-oxo-6E,14Z,12-prostatrienoic acid-cyclo[8R,12S]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110264
|
8,11-diepi-8-A2-IsoP
|
(R,5Z,9E)-8-hydroxy-10-((1S,5R)-2-oxo-5-pentylcyclopent-3-en-1-yl)deca-5,9-dienoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110283
|
8,11-diepi-8-J2-IsoP
|
(R,5Z,9E)-8-hydroxy-10-((1R,5S)-4-oxo-5-pentylcyclopent-2-en-1-yl)deca-5,9-dienoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110142
|
8,15-diepi-15-A2-IsoP
|
9-oxo-15R-hydroxy-5Z,10,13E-prostatrienoic acid-cyclo[8S,12R]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110135
|
8,15-diepi-15-J2c-IsoP
|
11-oxo-15R-hydroxy-5Z,9,13E-prostatrienoic acid-cyclo[8R,12S]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110133
|
8,15-diepi-15-J2t-IsoP
|
11-oxo-15R-hydroxy-5Z,9,13E-prostatrienoic acid-cyclo[8S,12R]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110266
|
8-A2-IsoP
|
(S,5Z,9E)-8-hydroxy-10-((1R,5R)-2-oxo-5-pentylcyclopent-3-en-1-yl)deca-5,9-dienoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110059
|
8-J2-IsoP
|
8S-hydroxy-14-oxo-5Z,9E,12-prostatrienoic acid-cyclo[11R,15S]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110141
|
8-epi-15-A2-IsoP
|
9-oxo-15S-hydroxy-5Z,10,13E-prostatrienoic acid-cyclo[8S,12R]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110114
|
8-epi-15-J2-IsoP
|
11-oxo-15S-hydroxy-5Z,9,13E-prostatrienoic acid-cyclo[8R,12S]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110258
|
8-epi-5-A2-IsoP
|
5S-hydroxy-9-oxo-6E,10,14Z-prostatrienoic acid-cyclo[8S,12R]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110278
|
8-epi-5-J2-IsoP
|
(S,E)-5-hydroxy-7-((S,E)-2-((Z)-oct-2-en-1-ylidene)-3-oxocyclopentyl)hept-6-enoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110265
|
8-epi-8-A2-IsoP
|
(R,5Z,9E)-8-hydroxy-10-((1R,5R)-2-oxo-5-pentylcyclopent-3-en-1-yl)deca-5,9-dienoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110060
|
8-epi-8-J2-IsoP
|
8R-hydroxy-14-oxo-5Z,9E,12-prostatrienoic acid-cyclo[11R,15S]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110267
|
ent-11-epi-8-A2-IsoP
|
(R,5Z,9E)-8-hydroxy-10-((1R,5S)-2-oxo-5-pentylcyclopent-3-en-1-yl)deca-5,9-dienoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110280
|
ent-11-epi-8-J2-IsoP
|
(R,5Z,9E)-8-hydroxy-10-((1S,5R)-4-oxo-5-pentylcyclopent-2-en-1-yl)deca-5,9-dienoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110252
|
ent-12-A2-IsoP
|
4-((1S,2S)-2-((R,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)butanoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110086
|
ent-12-J2-IsoP
|
12R-hydroxy-8-oxo-6,10E,14Z-prostatrienoic acid-cyclo[5R,9R]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110251
|
ent-12-epi-12-A2-IsoP
|
4-((1S,2S)-2-((S,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)butanoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110089
|
ent-12-epi-12-J2-IsoP
|
12S-hydroxy-8-oxo-6,10E,14Z-prostatrienoic acid-cyclo[5R,9R]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110137
|
ent-15-A2-IsoP
|
9-oxo-15R-hydroxy-5Z,10,13E-prostatrienoic acid-cyclo[8S,12S]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110100
|
ent-15-J2-IsoP
|
15R-hydroxy-11-oxo-5Z,9,13E-prostatrienoic acid-cyclo[8R,12R]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110140
|
ent-15-epi-15-A2-IsoP
|
9-oxo-15S-hydroxy-5Z,10,13E-prostatrienoic acid-cyclo[8S,12S]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110103
|
ent-15-epi-15-J2-IsoP
|
15S-hydroxy-11-oxo-5Z,9,13E-prostatrienoic acid-cyclo[8R,12R]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110253
|
ent-5,12-diepi-12-A2-IsoP
|
4-((1R,2S)-2-((S,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)butanoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110273
|
ent-5,12-diepi-12-J2-IsoP
|
4-((1S,5R)-5-((S,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)butanoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110259
|
ent-5,8-diepi-5-A2-IsoP
|
(S,E)-5-hydroxy-7-((1R,2S)-2-((Z)-oct-2-en-1-yl)-5-oxocyclopent-3-en-1-yl)hept-6-enoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110277
|
ent-5,8-diepi-5-J2-IsoP
|
(S,E)-5-hydroxy-7-((R,E)-2-((Z)-oct-2-en-1-ylidene)-3-oxocyclopentyl)hept-6-enoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110261
|
ent-5-A2-IsoP
|
(R,E)-5-hydroxy-7-((1S,2S)-2-((Z)-oct-2-en-1-yl)-5-oxocyclopent-3-en-1-yl)hept-6-enoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110071
|
ent-5-J2-IsoP
|
5R-hydroxy-11-oxo-6E,14Z,12-prostatrienoic acid-cyclo[8S,12R]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110254
|
ent-5-epi-12-A2-IsoP
|
4-((1R,2S)-2-((R,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)butanoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110272
|
ent-5-epi-12-J2-IsoP
|
4-((1S,5R)-5-((R,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)butanoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110260
|
ent-5-epi-5-A2-IsoP
|
(S,E)-5-hydroxy-7-((1S,2S)-2-((Z)-oct-2-en-1-yl)-5-oxocyclopent-3-en-1-yl)hept-6-enoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110074
|
ent-5-epi-5-J2-IsoP
|
5S-hydroxy-11-oxo-6E,14Z,12-prostatrienoic acid-cyclo[8S,12R]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110268
|
ent-8,11-diepi-8-A2-IsoP
|
(S,5Z,9E)-8-hydroxy-10-((1R,5S)-2-oxo-5-pentylcyclopent-3-en-1-yl)deca-5,9-dienoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110281
|
ent-8,11-diepi-8-J2-IsoP
|
(S,5Z,9E)-8-hydroxy-10-((1S,5R)-4-oxo-5-pentylcyclopent-2-en-1-yl)deca-5,9-dienoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110270
|
ent-8-A2-IsoP
|
(R,5Z,9E)-8-hydroxy-10-((1S,5S)-2-oxo-5-pentylcyclopent-3-en-1-yl)deca-5,9-dienoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110058
|
ent-8-J2-IsoP
|
8R-hydroxy-14-oxo-5Z,9E,12-prostatrienoic acid-cyclo[11S,15R]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110262
|
ent-8-epi-5-A2-IsoP
|
5S-hydroxy-9-oxo-6E,10,14Z-prostatrienoic acid-cyclo[8R,12S]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110276
|
ent-8-epi-5-J2-IsoP
|
(R,E)-5-hydroxy-7-((R,E)-2-((Z)-oct-2-en-1-ylidene)-3-oxocyclopentyl)hept-6-enoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110269
|
ent-8-epi-8-A2-IsoP
|
(S,5Z,9E)-8-hydroxy-10-((1S,5S)-2-oxo-5-pentylcyclopent-3-en-1-yl)deca-5,9-dienoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110061
|
ent-8-epi-8-J2-IsoP
|
8S-hydroxy-14-oxo-5Z,9E,12-prostatrienoic acid-cyclo[11S,15R]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03140006
|
18R-Resolvin E3
|
17R,18R-dihydroxy-5Z,8Z,11Z,13E,15E-eicosapentaenoic acid
|
Eicosanoids [FA03]
|
Resolvin Es [FA0314]
|
334.21
|
C20H30O4
|
|
LMFA03140004
|
18S-Resolvin E2
|
5S,18S-dihydroxy-6E,8Z,11Z,14Z,16E-eicosapentaenoic acid
|
Eicosanoids [FA03]
|
Resolvin Es [FA0314]
|
334.21
|
C20H30O4
|
|
LMFA03140007
|
18S-Resolvin E3
|
17R,18S-dihydroxy-5Z,8Z,11Z,13E,15E-eicosapentaenoic acid
|
Eicosanoids [FA03]
|
Resolvin Es [FA0314]
|
334.21
|
C20H30O4
|
|
LMFA03140011
|
Resolvin E2
|
5S,18R-dihydroxy-6E,8Z,11Z,14Z,16E-eicosapentaenoic acid
|
Eicosanoids [FA03]
|
Resolvin Es [FA0314]
|
334.21
|
C20H30O4
|
|
LMFA03140013
|
Resolvin E4
|
5S,15S-dihydroxy-6E,8Z,11Z,13E,17Z-eicosapentaenoic acid
|
Eicosanoids [FA03]
|
Resolvin Es [FA0314]
|
334.21
|
C20H30O4
|